Aeskulap International is combining conventional and complementary oncological treatments to create effective therapies for patients with metastatic and castration-resistant prostate cancer. This integrative approach includes basic complementary treatment measures, such as dietary- and lifestyle changes, specific physical therapy and exercise programs, psycho-oncology measures, hyperthermia- and fever therapies, detoxifying treatments, enzyme therapy and specifically designed medical treatments utilizing various plant derived preparations (phytotherapy).
In Western Europe prostate cancer is the most frequent malignant tumor type in man. Standard hormone-ablation therapies for men with recurring cancer after radical prostatectomy and / or radiation therapy often achieve only a short-term control of tumor growth. Due to clonal selection of hormone independent cancer cells, the so-called castration-resistant (formerly called hormone-refractory) stage of the disease develops in many of these patients. At this stage, therapeutic options are limited to “watch and wait” strategy, second-line hormonal therapies, or eventually chemotherapy which often causes significant side effects without truly extending the patient’s life.
Since each patient with advanced, metastatic, and castration-resistant prostate cancer is different, even if PSA levels and disease history might be similar, Aeskulap International offers tailor-made treatments including a supportive phytotherapy protocol for each individual patient. Depending on specific patient data, a special combination of phytotherapy compounds is chosen from the following product list for treatment: ProstaSol, Curcumin combi, BioBran, IMUPROS, Modified Citrus Pectin, Indole-3-Carbinol, IMUSAN, Convolvulus arvensis extract, and Artemisinin. In situations with very high PSA levels, aggressive tumor histology, and failing second line hormonal treatment (for example: Abiraterone – Zytiga and Enzalutamide – Xtandi), we also prescribe Aeskulap-Sitosterol-Mix, a tailor-made compound that greatly improves the efficacy of our phytotherapy protocol.
The following provides a short summary on the above-mentioned substances used in our treatment protocols; a more detailed information sheet for each substance as well as specific details about our treatment protocol can be requested from our office under:
ProstaSol™ contains various plant extracts, all known to support prostate health. The combination of Bio-Curcumin – a highly bio-available form of curcuma, LinumLife – a flax-seed extract rich in lignans, and Resveratrol – a strong antioxidant derived from grape seeds provides anti-inflammatory, anti-oxidative and anti-cancer properties.
Curcumin combi™ is a combination formula with extracts from Turmeric root and Resveratrol from Polygonum cuspidatum. It has powerful anti-oxidative, anti-inflammatory, and anti-tumour activities. Curcuma extracts are utilized worldwide in treatment protocols for patients with cancer. Their beneficial effects have been shown in more than 3000 studies.
IMUPROS™ is an orthomolecular combination formula, containing selenium, zinc and calcium, the vitamins C, D and E, as well as genistein, lycopene and epigallocatechin gallate; it provides the vitamins, minerals, and other vital substances necessary to maintain a healthy function of the prostate gland.
BioBran® is a processed rice bran polysaccharide containing Arabinoxylan as a major component which has a powerful immune modulation effect. This compound causes overall stimulation of the immune system. In particular, it increases the number and function of T-cells, B-cells, and NK-cells. BioBran also enhances apoptosis of cancer cells. The substance is non-toxic, and it is easily absorbed after oral intake. The effectiveness of BioBran has been documented in experimental and clinical studies published in peer-reviewed journals. At Aeskulap Hospital in Switzerland, BioBran is considered an important component of integrative tumour therapy for patients with prostate cancer and cancer in general.
Aeskulap CA-Statin contains Convolvulus arvensis extract with various proteoglycans which exert significant anti-angiogenesis effects reducing the blood supply to primary tumour as well as metastatic lesions. This is helping to slow down cancer growth.